| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.064 | 0.02 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.066 | 0.03 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |